 |
|
Colon cancer screening — Going 'Back To The Future'?
February 20, 2007INDIANAPOLIS — Colon cancer screening rates continue to lag behind those for breast and cervical cancer. In an editorial in the Feb. 20 edition of the Annals of Internal Medicine, Indiana University School of Medicine gastroenterologist and Regenstrief Institute, Inc. researcher Thomas Imperiale, M.D., writes that to increase screening rates for colorectal cancers, we need more convenient and less invasive screening tests. An infrequently used type of fecal sampling test, which has had Federal Drug Administration approval since 2001, may meet that need he says.
"In recent years, use of non-invasive screening has declined in favor of colonoscopy, but not everyone is willing to have a colonoscopy," said Dr. Imperiale, who is an IU School of Medicine professor of medicine. "The new immunochemical fecal occult blood test, referred to as I-FOBT, is a significant improvement over the older guaiac-based version. The newer fecal test has the potential to substantially increase screening rates for colorectal cancer, taking us back to the future in a sense." said Dr. Imperiale.
Unlike traditional fecal sampling tests which do not differentiate between blood from diet and blood from the digestive tract, I-FOBT uses antibodies to detect human blood in stool. This increased test specificity eliminates the need for dietary restrictions before colon cancer screening which may induce some individuals who are otherwise unwilling to take a screening test to do so.
Perhaps more importantly, the ability to choose different thresholds to indicate a positive result makes I-FOBT a test that can be used for individuals of any risk. "The test output (amount of hemoglobin per gram of stool) is a continuous variable, which means that a clinician can choose an I-FOBT positivity threshold to suit the patient's clinical characteristics such as age and reduce the chance of false positive test result," says Dr. Imperiale.
There are only a few examples of truly good screening tests for any cancer, according to Dr. Imperiale. He says that PAP smears are probably the best currently available screening tools because they are reasonably sensitive, specific and inexpensive, and the test itself has no risk. I-FOBT may be the comparable test for colon cancer screening, he concludes.
Colorectal cancer is the third most common cancer and the third leading cause of cancer related deaths in the United States. The National Cancer Institute estimates that more than 52,000 American will die of colorectal cancer in 2007.
Indiana University
Perhaps more importantly, the ability to choose different thresholds to indicate a positive result makes I-FOBT a test that can be used for individuals of any risk. "The test output (amount of hemoglobin per gram of stool) is a continuous variable, which means that a clinician can choose an I-FOBT positivity threshold to suit the patient's clinical characteristics such as age and reduce the chance of false positive test result," says Dr. Imperiale.
There are only a few examples of truly good screening tests for any cancer, according to Dr. Imperiale. He says that PAP smears are probably the best currently available screening tools because they are reasonably sensitive, specific and inexpensive, and the test itself has no risk. I-FOBT may be the comparable test for colon cancer screening, he concludes.
Colorectal cancer is the third most common cancer and the third leading cause of cancer related deaths in the United States. The National Cancer Institute estimates that more than 52,000 American will die of colorectal cancer in 2007.
Indiana University
Cancer Screening Current Events and Cancer Screening News RSSNew finding suggests prostate biopsy is not always necessary
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy.
Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer.
1 disease, not 1 demographic
The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander."
Study shows unsedated colonoscopy for colorectal cancer screening well accepted by patients
Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients.
M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers
Drawing on years of experience in cancer research and patient care, The University of Texas M. D. Anderson Cancer Center released today the most comprehensive, risk-based screening guidelines publicly available to date for breast, cervical and colorectal cancers.
Study finds delay in follow-up among African-American women receiving abnormal breast finding
A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality.
Physicians have less respect for obese patients, study suggests
Doctors have less respect for their obese patients than they do for patients of normal weight, a new study by Johns Hopkins researchers suggests. The findings raise questions about whether negative physician attitudes about obesity could be affecting the long-term health of their heavier patients.
Experts issue call to reconsider screening for breast cancer and prostate cancer
Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."
UIC study finds girls aware of HPV vaccine's benefits
Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections.
Vaccinating boys against human papillomavirus not cost-effective
Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer.
More Cancer Screening Current Events and Cancer Screening News Articles
 |
Should I Be Tested for Cancer?: Maybe Not and Here's Why by H. Gilbert Welch M.D. M.P.H. (Author) Getting tested to detect cancer early is one of the best ways to stay healthy--or is it? In this lively, carefully researched book, a nationally recognized expert on early cancer detection challenges one of medicine's most widely accepted beliefs: that the best defense against cancer is to always try to catch it early. Read this book and you will think twice about common cancer screening tests such as total body scans, mammograms, and prostate-specific antigen (PSA) tests. Combining patient stories and solid data on common cancers, Dr. H. Gilbert Welch makes the case that testing healthy people for cancer is really a double-edged sword: while these tests may help, they often have surprisingly little effect and are sometimes even harmful. Bringing together a body of little-known... |
 |
Genitourinary Trauma Diagnosis and Management in the Emergency Department/Breast Cancer Screening By Mammography Is It Effective in Women Under Age 50? (NCME Video 673) Also With: Network For Continuing Medical Education (Primary Contributor), Robert E Schneider (Primary Contributor), Barbara K Rimer (Primary Contributor) Program I (30 min.) -- Genitourinary injury is often very subtle and sometimes not apparent until several hours after it occurs. This program reviews the diagnosis, evaluation, and management of both upper and lower genitourinary trauma in the acute care setting. Program II (12 min.) -- The questions of which women to screen for breast cancer by mammography, at what age, and how often have generated more controversy than perhaps any other medical intervention. This program reviews the data on screening women under age 50 and attempts to provide an evidence-based foundation for informed decision-making by health care professionals. |
 |
Understanding Prostate Cancer (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. Are you a man age 40 or older and haven't had a PSA test for Prostate Cancer? Prostate cancer is the most common cancer in men, after skin cancer. It is estimated that approximately 230,110 men in the United States will be diagnosed with the disease this year, and about 30,000 men will die from it. PSA or Prostate Specific Antigen is a simple blood test that can save your life. In this episode, patients and doctors explain what the PSA test is and how it can be used to identify cancer at its earliest stage. Remember, no man should die from Prostate Cancer. Watch this program and get the facts. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will... |
 |
Beckman Coulter Hemoccult II Dispensapak Plus, 40 Screening Kits and 2 15 ml Bottles of Develope by Beckman Coulter Each box contains: 40 Patient Screening Kits. Two 15 mL bottles of Hemoccult developer. The product referenced on this detail page is sold be Box. |
 |
Cancer Prevention and Screening for the Ultimate Thriving Machine by Ultimate Thriving Machine A unique calendar designed to educate men on how they can keep their body, the "Ultimate Thriving Machine", in tip top condition. Our goal is to inform men in a straight forward way, to care for their bodies as they care for their favorite vehicle, with routine maintenance and prevention of health problems including cancer. |
 |
Cancer Screening And Detection Dr. Andrew Weil (Primary Contributor) |
 |
Understanding the Mammography Controversy: Science, Politics, and Breast Cancer Screening by Madelon L. Finkel (Author) Writing to be understood by the layreader, Finkel shows how breast cancer develops and explains the controversy surrounding mammography. How valid are the screenings? Who should be screened? How frequently? At what age? Should women be screened at all? This book dissects the issues to help present answers. Above all, says Finkel. Women need to make informed decisions, and to do what they need to understand the potential benefits and potential harms accompanying mammography. This book includes a timeline showing changing public advice on mammography across the years. Listings explain how to see federal reports on mammography facilites and how to find and contact support groups. Finkel details the development of breast cancer and its various types of tumors, the treatment... |
|
EarlyDetect Colon Screening, 1-Count Box (Pack of 2) by EarlyDETECT | |
|
Advancements in Colon Cancer Screening: From the Basics to the 'Virtual' (Health Talks at the Cleveland Clinic) | |
 |
The Secrets of Medical Decision Making: How to Avoid Becoming a Victim of the Health Care Machine by Oleg I. Reznik (Author) We are all patients at some time. Is the medical industry giving us the best treatment possible, at the best price? We all know that it isn’t. My book, The Secrets of Medical Decision Making: How to avoid becoming a victim of the Health Care Machine, shows what goes on behind the scenes of the current medical care and how it impacts the patient. I describe actual cases from my clinical practice showing the most common paths that lead to increased patient suffering. I then offer possible solutions. My book covers all the health care settings a reader may encounter: outpatient (the most common type of health care setting encountered by patients), the inpatient (hospital), preventive (patients who are not sick but seek preventive services), and end-of-life care setting. The... |
| © 2009 BrightSurf.com |